Calimmune, Inc. clinical trials
Acquired by CSL Limited, Aug 31, 2017 · source ↗
The registry lists 2 studies whose lead sponsor is Calimmune, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 10, 2025.
Before and after it joined CSL Limited
- First submitted before Calimmune, Inc. became part of CSL Limited
- 2
- First submitted after Calimmune, Inc. became part of CSL Limited
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Calimmune, Inc.2 studies
Something wrong with this grouping? Tell us on the CSL Limited page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All CSL Limited studies →
- Long Term Follow up for the Detection of Delayed Adverse Events in Cal-1 RecipientsActive, not recruitingNCT02390297
Sponsor listed in the registry: Calimmune, Inc. · First submitted before Calimmune, Inc. became part of CSL Limited
- Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 InfectionCompletedNCT01734850Phase 1/2
Sponsor listed in the registry: Calimmune, Inc. · First submitted before Calimmune, Inc. became part of CSL Limited